메뉴 건너뛰기




Volumn 175, Issue 14, 2018, Pages 2770-2777

The dynamic interaction between pain and opioid misuse

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE; MU OPIATE RECEPTOR AGONIST; OPIATE; PZM 21; NARCOTIC ANALGESIC AGENT;

EID: 85021400521     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.13873     Document Type: Review
Times cited : (32)

References (116)
  • 2
    • 84976528239 scopus 로고    scopus 로고
    • Will peripherally restricted kappa-opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential?
    • Albert-Vartanian A, Boyd MR, Hall AL, Morgado SJ, Nguyen E, Nguyen VP et al. (2016). Will peripherally restricted kappa-opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential? J Clin Pharm Ther 41: 371–382.
    • (2016) J Clin Pharm Ther , vol.41 , pp. 371-382
    • Albert-Vartanian, A.1    Boyd, M.R.2    Hall, A.L.3    Morgado, S.J.4    Nguyen, E.5    Nguyen, V.P.6
  • 5
    • 84940545408 scopus 로고    scopus 로고
    • Distinct subpopulations of nucleus accumbens dynorphin neurons drive aversion and reward
    • Al-Hasani R, McCall JG, Shin G, Gomez AM, Schmitz GP, Bernardi JM et al. (2015). Distinct subpopulations of nucleus accumbens dynorphin neurons drive aversion and reward. Neuron 87: 1063–1077.
    • (2015) Neuron , vol.87 , pp. 1063-1077
    • Al-Hasani, R.1    McCall, J.G.2    Shin, G.3    Gomez, A.M.4    Schmitz, G.P.5    Bernardi, J.M.6
  • 7
    • 80051986275 scopus 로고    scopus 로고
    • Nonmedical prescription opioid use and mental health and pain comorbidities: a narrative review
    • Amari E, Rehm J, Goldner E, Fischer B (2011). Nonmedical prescription opioid use and mental health and pain comorbidities: a narrative review. Can J Psychiatry 56: 495–502.
    • (2011) Can J Psychiatry , vol.56 , pp. 495-502
    • Amari, E.1    Rehm, J.2    Goldner, E.3    Fischer, B.4
  • 8
    • 84857884111 scopus 로고    scopus 로고
    • [Online], (accessed 1/16/17)
    • Australian Government Department of Health, Therapeutic Goods Administration (2008). Best Practice Guideline on Prescription Medicine Labelling. [Online] Available at: https://www.tga.gov.au/publication/best-practice-guideline-prescription-medicine-labelling (accessed 1/16/17).
    • (2008) Best Practice Guideline on Prescription Medicine Labelling
  • 10
    • 0242658912 scopus 로고    scopus 로고
    • Opioid therapy for chronic pain
    • Ballantyne JC, Mao J (2003). Opioid therapy for chronic pain. N Engl J Med 349: 1943–1953.
    • (2003) N Engl J Med , vol.349 , pp. 1943-1953
    • Ballantyne, J.C.1    Mao, J.2
  • 11
    • 84930517040 scopus 로고    scopus 로고
    • Does mindfulness improve outcomes in patients with chronic pain? Systematic review and meta-analysis
    • Bawa FL, Mercer SW, Atherton RJ, Clague F, Keen A, Scott NW et al. (2015). Does mindfulness improve outcomes in patients with chronic pain? Systematic review and meta-analysis. Br J Gen Pract 65: e387–e400.
    • (2015) Br J Gen Pract , vol.65 , pp. e387-e400
    • Bawa, F.L.1    Mercer, S.W.2    Atherton, R.J.3    Clague, F.4    Keen, A.5    Scott, N.W.6
  • 12
    • 84862338136 scopus 로고    scopus 로고
    • Cerebral interactions of pain and reward and their relevance for chronic pain
    • Becker S, Gandhi W, Schweinhardt P (2012). Cerebral interactions of pain and reward and their relevance for chronic pain. Neurosci Lett 520: 182–187.
    • (2012) Neurosci Lett , vol.520 , pp. 182-187
    • Becker, S.1    Gandhi, W.2    Schweinhardt, P.3
  • 13
    • 85048983764 scopus 로고    scopus 로고
    • [Online], (accessed January 16
    • Best Practice Guideline on Prescription Medicine Labelling. [Online] Available at https://www.tga.gov.au/publication/best-practice-guideline-prescription-medicine-labelling. (accessed January 16, 2017a).
    • (2017) Best Practice Guideline on Prescription Medicine Labelling
  • 14
    • 84964297917 scopus 로고    scopus 로고
    • Medical cannabis use is associated with decreased opiate medication use in a retrospective cross-sectional survey of patients with chronic pain
    • Boehnke KF, Litinas E, Clauw DJ (2016). Medical cannabis use is associated with decreased opiate medication use in a retrospective cross-sectional survey of patients with chronic pain. J Pain 17: 739–744.
    • (2016) J Pain , vol.17 , pp. 739-744
    • Boehnke, K.F.1    Litinas, E.2    Clauw, D.J.3
  • 15
    • 85048980179 scopus 로고    scopus 로고
    • [Online], on PDMP Effectiveness 3rd revision.pdf (accessed January 16
    • Briefing on PDMP Effectiveness. [Online] Available at: http://www.pdmpassist.org/pdf/COE_documents/Add_to_TTAC/Briefing on PDMP Effectiveness 3rd revision.pdf (accessed January 16, 2017b).
    • (2017) Briefing on PDMP Effectiveness
  • 17
    • 84887994707 scopus 로고
    • APS 1995 presidential address
    • Campbell JN (1995). APS 1995 presidential address. J Pain 5: 85–88.
    • (1995) J Pain , vol.5 , pp. 85-88
    • Campbell, J.N.1
  • 18
    • 84856506438 scopus 로고    scopus 로고
    • CDC grand rounds: prescription drug overdoses – a U.S. epidemic
    • Centers for Disease Control and Prevention (2012). CDC grand rounds: prescription drug overdoses – a U.S. epidemic. MMWR Morb Mortal Wkly Rep 61: 10–13.
    • (2012) MMWR Morb Mortal Wkly Rep , vol.61 , pp. 10-13
  • 19
    • 0030991539 scopus 로고    scopus 로고
    • Prescription opiate abuse in chronic pain patients: clinical criteria, incidence, and predictors
    • Chabal C, Erjavec MK, Jacobson L, Mariano A, Chaney E (1997). Prescription opiate abuse in chronic pain patients: clinical criteria, incidence, and predictors. Clin J Pain 13: 150–155.
    • (1997) Clin J Pain , vol.13 , pp. 150-155
    • Chabal, C.1    Erjavec, M.K.2    Jacobson, L.3    Mariano, A.4    Chaney, E.5
  • 20
    • 69249143742 scopus 로고    scopus 로고
    • 2009 clinical guidelines from the American Pain Society and the American Academy of Pain Medicine on the use of chronic opioid therapy in chronic noncancer pain: what are the key messages for clinical practice?
    • Chou R (2009). 2009 clinical guidelines from the American Pain Society and the American Academy of Pain Medicine on the use of chronic opioid therapy in chronic noncancer pain: what are the key messages for clinical practice? Pol Arch Med Wewn 119: 469–477.
    • (2009) Pol Arch Med Wewn , vol.119 , pp. 469-477
    • Chou, R.1
  • 22
    • 84946059139 scopus 로고    scopus 로고
    • Shifting patterns of prescription opioid and heroin abuse in the United States
    • Cicero TJ, Ellis MS, Harney J (2015). Shifting patterns of prescription opioid and heroin abuse in the United States. N Engl J Med 373: 1789–1790.
    • (2015) N Engl J Med , vol.373 , pp. 1789-1790
    • Cicero, T.J.1    Ellis, M.S.2    Harney, J.3
  • 23
    • 0037373238 scopus 로고    scopus 로고
    • Antinociceptive synergy between delta(9)-tetrahydrocannabinol and opioids after oral administration
    • Cichewicz DL, McCarthy EA (2003). Antinociceptive synergy between delta(9)-tetrahydrocannabinol and opioids after oral administration. J Pharmacol Exp Ther 304: 1010–1015.
    • (2003) J Pharmacol Exp Ther , vol.304 , pp. 1010-1015
    • Cichewicz, D.L.1    McCarthy, E.A.2
  • 24
    • 0032415875 scopus 로고    scopus 로고
    • Screening for addiction in patients with chronic pain and ‘problematic’ substance use: evaluation of a pilot assessment tool
    • Compton P, Darakjian J, Miotto K (1998). Screening for addiction in patients with chronic pain and ‘problematic’ substance use: evaluation of a pilot assessment tool. J Pain Symptom Manage 16: 355–363.
    • (1998) J Pain Symptom Manage , vol.16 , pp. 355-363
    • Compton, P.1    Darakjian, J.2    Miotto, K.3
  • 26
    • 34648829826 scopus 로고    scopus 로고
    • Behavioral counseling content for optimizing the use of buprenorphine for treatment of opioid dependence in community-based settings: a review of the empirical evidence
    • Copenhaver MM, Bruce RD, Altice FL (2007). Behavioral counseling content for optimizing the use of buprenorphine for treatment of opioid dependence in community-based settings: a review of the empirical evidence. Am J Drug Alcohol Abuse 33: 643–654.
    • (2007) Am J Drug Alcohol Abuse , vol.33 , pp. 643-654
    • Copenhaver, M.M.1    Bruce, R.D.2    Altice, F.L.3
  • 27
    • 34249108566 scopus 로고    scopus 로고
    • Synergy between delta9-tetrahydrocannabinol and morphine in the arthritic rat
    • Cox ML, Haller VL, Welch SP (2007). Synergy between delta9-tetrahydrocannabinol and morphine in the arthritic rat. Eur J Pharmacol 567: 125–130.
    • (2007) Eur J Pharmacol , vol.567 , pp. 125-130
    • Cox, M.L.1    Haller, V.L.2    Welch, S.P.3
  • 28
    • 84941877027 scopus 로고    scopus 로고
    • Smartphone and mobile application utilization prior to and following treatment among individuals enrolled in residential substance use treatment
    • Dahne J, Lejuez CW (2015). Smartphone and mobile application utilization prior to and following treatment among individuals enrolled in residential substance use treatment. J Subst Abuse Treat 58: 95–99.
    • (2015) J Subst Abuse Treat , vol.58 , pp. 95-99
    • Dahne, J.1    Lejuez, C.W.2
  • 29
    • 84942744640 scopus 로고    scopus 로고
    • Impact of chronic pain on treatment prognosis for patients with opioid use disorder: a systematic review and meta-analysis
    • Dennis BB, Bawor M, Naji L, Chan CK, Varenbut J, Paul J et al. (2015). Impact of chronic pain on treatment prognosis for patients with opioid use disorder: a systematic review and meta-analysis. Subst Abuse 9: 59–80.
    • (2015) Subst Abuse , vol.9 , pp. 59-80
    • Dennis, B.B.1    Bawor, M.2    Naji, L.3    Chan, C.K.4    Varenbut, J.5    Paul, J.6
  • 30
    • 0027847675 scopus 로고
    • Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies
    • Devine DP, Leone P, Pocock D, Wise RA (1993). Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies. J Pharmacol Exp Ther 266: 1236–1246.
    • (1993) J Pharmacol Exp Ther , vol.266 , pp. 1236-1246
    • Devine, D.P.1    Leone, P.2    Pocock, D.3    Wise, R.A.4
  • 31
    • 84942083756 scopus 로고    scopus 로고
    • Effects of acute and chronic social defeat stress are differentially mediated by the dynorphin/kappa-opioid receptor system
    • Donahue RJ, Landino SM, Golden SA, Carroll FI, Russo SJ, Carlezon WA Jr (2015). Effects of acute and chronic social defeat stress are differentially mediated by the dynorphin/kappa-opioid receptor system. Behav Pharmacol 26: 654–663.
    • (2015) Behav Pharmacol , vol.26 , pp. 654-663
    • Donahue, R.J.1    Landino, S.M.2    Golden, S.A.3    Carroll, F.I.4    Russo, S.J.5    Carlezon, W.A.6
  • 32
    • 84888640391 scopus 로고    scopus 로고
    • A blueprint of pain curriculum across prelicensure health sciences programs: one NIH Pain Consortium Center of Excellence in Pain Education (CoEPE) experience
    • Doorenbos AZ, Gordon DB, Tauben D, Palisoc J, Drangsholt M, Lindhorst T et al. (2013). A blueprint of pain curriculum across prelicensure health sciences programs: one NIH Pain Consortium Center of Excellence in Pain Education (CoEPE) experience. J Pain 14: 1533–1538.
    • (2013) J Pain , vol.14 , pp. 1533-1538
    • Doorenbos, A.Z.1    Gordon, D.B.2    Tauben, D.3    Palisoc, J.4    Drangsholt, M.5    Lindhorst, T.6
  • 33
    • 84964402250 scopus 로고    scopus 로고
    • CDC guideline for prescribing opioids for chronic pain – United States, 2016
    • Dowell D, Haegerich TM, Chou R (2016). CDC guideline for prescribing opioids for chronic pain – United States, 2016. JAMA 315: 1624–1645.
    • (2016) JAMA , vol.315 , pp. 1624-1645
    • Dowell, D.1    Haegerich, T.M.2    Chou, R.3
  • 34
    • 84985032686 scopus 로고    scopus 로고
    • Opioid overdose experience, risk behaviors, and knowledge in drug users from a rural versus an urban setting
    • Dunn KE, Barrett FS, Yepez-Laubach C, Meyer AC, Hruska BJ, Petrush K et al. (2016). Opioid overdose experience, risk behaviors, and knowledge in drug users from a rural versus an urban setting. J Subst Abuse Treat 71: 1–7.
    • (2016) J Subst Abuse Treat , vol.71 , pp. 1-7
    • Dunn, K.E.1    Barrett, F.S.2    Yepez-Laubach, C.3    Meyer, A.C.4    Hruska, B.J.5    Petrush, K.6
  • 35
    • 84979202573 scopus 로고    scopus 로고
    • Innovative program targets five common pain syndromes with non-opioid alternatives
    • ED Management (2016). Innovative program targets five common pain syndromes with non-opioid alternatives. ED Manag 28: 61–66.
    • (2016) ED Manag , vol.28 , pp. 61-66
  • 36
  • 37
    • 44249119043 scopus 로고    scopus 로고
    • What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review
    • Fishbain DA, Cole B, Lewis J, Rosomoff HL, Rosomoff RS (2008). What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review. Pain Med 9: 444–459.
    • (2008) Pain Med , vol.9 , pp. 444-459
    • Fishbain, D.A.1    Cole, B.2    Lewis, J.3    Rosomoff, H.L.4    Rosomoff, R.S.5
  • 38
    • 84889659843 scopus 로고    scopus 로고
    • The downward spiral of chronic pain, prescription opioid misuse, and addiction: cognitive, affective, and neuropsychopharmacologic pathways
    • Garland EL, Froeliger B, Zeidan F, Partin K, Howard MO (2013). The downward spiral of chronic pain, prescription opioid misuse, and addiction: cognitive, affective, and neuropsychopharmacologic pathways. Neurosci Biobehav Rev 37: 2597–2607.
    • (2013) Neurosci Biobehav Rev , vol.37 , pp. 2597-2607
    • Garland, E.L.1    Froeliger, B.2    Zeidan, F.3    Partin, K.4    Howard, M.O.5
  • 41
    • 84941089593 scopus 로고    scopus 로고
    • Cis-expression quantitative trait loci mapping reveals replicable associations with heroin addiction in OPRM1
    • Hancock DB, Levy JL, Gaddis NC, Glasheen C, Saccone NL, Page GP et al. (2015). Cis-expression quantitative trait loci mapping reveals replicable associations with heroin addiction in OPRM1. Biol Psychiatry 78: 474–484.
    • (2015) Biol Psychiatry , vol.78 , pp. 474-484
    • Hancock, D.B.1    Levy, J.L.2    Gaddis, N.C.3    Glasheen, C.4    Saccone, N.L.5    Page, G.P.6
  • 42
    • 84958787528 scopus 로고    scopus 로고
    • The effect of medicinal cannabis on pain and quality-of-life outcomes in chronic pain: a prospective open-label study
    • Haroutounian S, Ratz Y, Ginosar Y, Furmanov K, Saifi F, Meidan R et al. (2016). The effect of medicinal cannabis on pain and quality-of-life outcomes in chronic pain: a prospective open-label study. Clin J Pain 32: 1036–1043.
    • (2016) Clin J Pain , vol.32 , pp. 1036-1043
    • Haroutounian, S.1    Ratz, Y.2    Ginosar, Y.3    Furmanov, K.4    Saifi, F.5    Meidan, R.6
  • 43
    • 84866491179 scopus 로고    scopus 로고
    • Prevalence of complementary and alternative medicine (CAM) use by the general population: a systematic review and update
    • Harris PE, Cooper KL, Relton C, Thomas KJ (2012). Prevalence of complementary and alternative medicine (CAM) use by the general population: a systematic review and update. Int J Clin Pract 66: 924–939.
    • (2012) Int J Clin Pract , vol.66 , pp. 924-939
    • Harris, P.E.1    Cooper, K.L.2    Relton, C.3    Thomas, K.J.4
  • 45
    • 84940952898 scopus 로고    scopus 로고
    • Inflammatory pain promotes increased opioid self-administration: role of dysregulated ventral tegmental area mu opioid receptors
    • Hipolito L, Wilson-Poe A, Campos-Jurado Y, Zhong E, Gonzalez-Romero J, Virag L et al. (2015). Inflammatory pain promotes increased opioid self-administration: role of dysregulated ventral tegmental area mu opioid receptors. J Neurosci 35: 12217–12231.
    • (2015) J Neurosci , vol.35 , pp. 12217-12231
    • Hipolito, L.1    Wilson-Poe, A.2    Campos-Jurado, Y.3    Zhong, E.4    Gonzalez-Romero, J.5    Virag, L.6
  • 47
    • 85027929537 scopus 로고    scopus 로고
    • A randomized trial of a pain management intervention for adults receiving substance use disorder treatment
    • Ilgen MA, Bohnert AS, Chermack S, Conran C, Jannausch M, Trafton J et al. (2016). A randomized trial of a pain management intervention for adults receiving substance use disorder treatment. Addiction 111: 1385–1393.
    • (2016) Addiction , vol.111 , pp. 1385-1393
    • Ilgen, M.A.1    Bohnert, A.S.2    Chermack, S.3    Conran, C.4    Jannausch, M.5    Trafton, J.6
  • 49
    • 0033955297 scopus 로고    scopus 로고
    • Characteristics of methadone maintenance patients with chronic pain
    • Jamison RN, Kauffman J, Katz NP (2000). Characteristics of methadone maintenance patients with chronic pain. J Pain Symptom Manage 19: 53–62.
    • (2000) J Pain Symptom Manage , vol.19 , pp. 53-62
    • Jamison, R.N.1    Kauffman, J.2    Katz, N.P.3
  • 50
    • 78149285273 scopus 로고    scopus 로고
    • The prevalence of chronic pain in United States adults: results of an Internet-based survey
    • Johannes CB, Le TK, Zhou X, Johnston JA, Dworkin RH (2010). The prevalence of chronic pain in United States adults: results of an Internet-based survey. J Pain 11: 1230–1239.
    • (2010) J Pain , vol.11 , pp. 1230-1239
    • Johannes, C.B.1    Le, T.K.2    Zhou, X.3    Johnston, J.A.4    Dworkin, R.H.5
  • 51
    • 84882452814 scopus 로고    scopus 로고
    • An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics
    • Johnson JR, Lossignol D, Burnell-Nugent M, Fallon MT (2013). An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics. J Pain Symptom Manage 46: 207–218.
    • (2013) J Pain Symptom Manage , vol.46 , pp. 207-218
    • Johnson, J.R.1    Lossignol, D.2    Burnell-Nugent, M.3    Fallon, M.T.4
  • 55
    • 84876310253 scopus 로고    scopus 로고
    • Injectable, cellular-scale optoelectronics with applications for wireless optogenetics
    • Kim TI, McCall JG, Jung YH, Huang X, Siuda ER, Li Y et al. (2013). Injectable, cellular-scale optoelectronics with applications for wireless optogenetics. Science 340: 211–216.
    • (2013) Science , vol.340 , pp. 211-216
    • Kim, T.I.1    McCall, J.G.2    Jung, Y.H.3    Huang, X.4    Siuda, E.R.5    Li, Y.6
  • 57
    • 0037407734 scopus 로고    scopus 로고
    • Management of drug and alcohol withdrawal
    • Kosten TR, O'Connor PG (2003). Management of drug and alcohol withdrawal. N Engl J Med 348: 1786–1795.
    • (2003) N Engl J Med , vol.348 , pp. 1786-1795
    • Kosten, T.R.1    O'Connor, P.G.2
  • 58
    • 73149124507 scopus 로고    scopus 로고
    • Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking
    • Land BB, Bruchas MR, Schattauer S, Giardino WJ, Aita M, Messinger D et al. (2009). Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking. Proc Natl Acad Sci U S A 106: 19168–19173.
    • (2009) Proc Natl Acad Sci U S A , vol.106 , pp. 19168-19173
    • Land, B.B.1    Bruchas, M.R.2    Schattauer, S.3    Giardino, W.J.4    Aita, M.5    Messinger, D.6
  • 59
    • 79955641980 scopus 로고    scopus 로고
    • Definitions related to the use of pharmaceutical opioids: extramedical use, diversion, non-adherence and aberrant medication-related behaviours
    • Larance B, Degenhardt L, Lintzeris N, Winstock A, Mattick R (2011). Definitions related to the use of pharmaceutical opioids: extramedical use, diversion, non-adherence and aberrant medication-related behaviours. Drug Alcohol Rev 30: 236–245.
    • (2011) Drug Alcohol Rev , vol.30 , pp. 236-245
    • Larance, B.1    Degenhardt, L.2    Lintzeris, N.3    Winstock, A.4    Mattick, R.5
  • 63
    • 84984612101 scopus 로고    scopus 로고
    • Structure-based discovery of opioid analgesics with reduced side effects
    • Manglik A, Lin H, Aryal DK, McCorvy JD, Dengler D, Corder G et al. (2016). Structure-based discovery of opioid analgesics with reduced side effects. Nature 537: 185–190.
    • (2016) Nature , vol.537 , pp. 185-190
    • Manglik, A.1    Lin, H.2    Aryal, D.K.3    McCorvy, J.D.4    Dengler, D.5    Corder, G.6
  • 64
    • 84937242988 scopus 로고    scopus 로고
    • Heroin-related overdose: the unexplored influences of markets, marketing and source-types in the United States
    • Mars SG, Fessel JN, Bourgois P, Montero F, Karandinos G, Ciccarone D (2015). Heroin-related overdose: the unexplored influences of markets, marketing and source-types in the United States. Soc Sci Med 140: 44–53.
    • (2015) Soc Sci Med , vol.140 , pp. 44-53
    • Mars, S.G.1    Fessel, J.N.2    Bourgois, P.3    Montero, F.4    Karandinos, G.5    Ciccarone, D.6
  • 65
    • 33846939014 scopus 로고    scopus 로고
    • Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction
    • Martell BA, O'Connor PG, Kerns RD, Becker WC, Morales KH, Kosten TR et al. (2007). Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med 146: 116–127.
    • (2007) Ann Intern Med , vol.146 , pp. 116-127
    • Martell, B.A.1    O'Connor, P.G.2    Kerns, R.D.3    Becker, W.C.4    Morales, K.H.5    Kosten, T.R.6
  • 66
    • 84936881487 scopus 로고    scopus 로고
    • Chronic back pain is associated with alterations in dopamine neurotransmission in the ventral striatum
    • Martikainen IK, Nuechterlein EB, Pecina M, Love TM, Cummiford CM, Green CR et al. (2015). Chronic back pain is associated with alterations in dopamine neurotransmission in the ventral striatum. J Neurosci 35: 9957–9965.
    • (2015) J Neurosci , vol.35 , pp. 9957-9965
    • Martikainen, I.K.1    Nuechterlein, E.B.2    Pecina, M.3    Love, T.M.4    Cummiford, C.M.5    Green, C.R.6
  • 68
    • 84946423565 scopus 로고    scopus 로고
    • Prescription monitoring programs and emergency department visits involving opioids, 2004–2011
    • Maughan BC, Bachhuber MA, Mitra N, Starrels JL (2015). Prescription monitoring programs and emergency department visits involving opioids, 2004–2011. Drug Alcohol Depend 156: 282–288.
    • (2015) Drug Alcohol Depend , vol.156 , pp. 282-288
    • Maughan, B.C.1    Bachhuber, M.A.2    Mitra, N.3    Starrels, J.L.4
  • 70
    • 85018506438 scopus 로고    scopus 로고
    • [Online], (accessed October 26
    • Medscape Physician Compensation Report 2016. [Online] Available at: http://www.medscape.com/features/slideshow/compensation/2016/public/overview-page=1 (accessed October 26, 2016).
    • (2016) Medscape Physician Compensation Report 2016
  • 72
    • 84928800803 scopus 로고    scopus 로고
    • The promises and pitfalls of digital technology in its application to alcohol treatment
    • Muench F (2014). The promises and pitfalls of digital technology in its application to alcohol treatment. Alcohol Res 36: 131–142.
    • (2014) Alcohol Res , vol.36 , pp. 131-142
    • Muench, F.1
  • 73
    • 1642285946 scopus 로고    scopus 로고
    • Molecular mechanism of changes in the morphine-induced pharmacological actions under chronic pain-like state: suppression of dopaminergic transmission in the brain
    • Narita M, Suzuki M, Imai S, Narita M, Ozaki S, Kishimoto Y et al. (2004). Molecular mechanism of changes in the morphine-induced pharmacological actions under chronic pain-like state: suppression of dopaminergic transmission in the brain. Life Sci 74: 2655–2673.
    • (2004) Life Sci , vol.74 , pp. 2655-2673
    • Narita, M.1    Suzuki, M.2    Imai, S.3    Narita, M.4    Ozaki, S.5    Kishimoto, Y.6
  • 74
    • 84964567818 scopus 로고    scopus 로고
    • [Online], (accessed January 16
    • National Heroin Threat Assessment Summary. [Online] Available at: https://www.dea.gov/divisions/hq/2016/hq062716_attach.pdf (accessed January 16, 2017d).
    • (2017) National Heroin Threat Assessment Summary
  • 75
    • 84874444262 scopus 로고    scopus 로고
    • Pain relief produces negative reinforcement through activation of mesolimbic reward-valuation circuitry
    • Navratilova E, Xie JY, Okun A, Qu C, Eyde N, Ci S et al. (2012). Pain relief produces negative reinforcement through activation of mesolimbic reward-valuation circuitry. Proc Natl Acad Sci U S A 109: 20709–20713.
    • (2012) Proc Natl Acad Sci U S A , vol.109 , pp. 20709-20713
    • Navratilova, E.1    Xie, J.Y.2    Okun, A.3    Qu, C.4    Eyde, N.5    Ci, S.6
  • 77
    • 77954029811 scopus 로고    scopus 로고
    • Neuropathic and chronic pain stimuli downregulate central mu-opioid and dopaminergic transmission
    • Niikura K, Narita M, Butelman ER, Kreek MJ, Suzuki T (2010). Neuropathic and chronic pain stimuli downregulate central mu-opioid and dopaminergic transmission. Trends Pharmacol Sci 31: 299–305.
    • (2010) Trends Pharmacol Sci , vol.31 , pp. 299-305
    • Niikura, K.1    Narita, M.2    Butelman, E.R.3    Kreek, M.J.4    Suzuki, T.5
  • 78
    • 84979684903 scopus 로고    scopus 로고
    • Patient vs provider reports of aberrant medication-taking behavior among opioid-treated patients with chronic pain who report misusing opioid medication
    • Nikulina V, Guarino H, Acosta MC, Marsch LA, Syckes C, Moore SK et al. (2016). Patient vs provider reports of aberrant medication-taking behavior among opioid-treated patients with chronic pain who report misusing opioid medication. Pain 157: 1791–1798.
    • (2016) Pain , vol.157 , pp. 1791-1798
    • Nikulina, V.1    Guarino, H.2    Acosta, M.C.3    Marsch, L.A.4    Syckes, C.5    Moore, S.K.6
  • 79
    • 84868204703 scopus 로고    scopus 로고
    • Distinguishing features of cancer patients who smoke: pain, symptom burden, and risk for opioid misuse
    • Novy DM, Lam C, Gritz ER, Hernandez M, Driver LC, Koyyalagunta D (2012). Distinguishing features of cancer patients who smoke: pain, symptom burden, and risk for opioid misuse. J Pain 13: 1058–1067.
    • (2012) J Pain , vol.13 , pp. 1058-1067
    • Novy, D.M.1    Lam, C.2    Gritz, E.R.3    Hernandez, M.4    Driver, L.C.5    Koyyalagunta, D.6
  • 80
    • 84877073812 scopus 로고    scopus 로고
    • A population pharmacokinetic and pharmacodynamic study of a peripheral kappa-opioid receptor agonist CR665 and oxycodone
    • Olesen AE, Kristensen K, Staahl C, Kell S, Wong GY, Arendt-Nielsen L et al. (2013). A population pharmacokinetic and pharmacodynamic study of a peripheral kappa-opioid receptor agonist CR665 and oxycodone. Clin Pharmacokinet 52: 125–137.
    • (2013) Clin Pharmacokinet , vol.52 , pp. 125-137
    • Olesen, A.E.1    Kristensen, K.2    Staahl, C.3    Kell, S.4    Wong, G.Y.5    Arendt-Nielsen, L.6
  • 81
    • 84980368213 scopus 로고    scopus 로고
    • Implementation of prescription drug monitoring programs associated with reductions in opioid-related death rates
    • Patrick SW, Fry CE, Jones TF, Buntin MB (2016). Implementation of prescription drug monitoring programs associated with reductions in opioid-related death rates. Health Aff (Millwood) 35: 1324–1332.
    • (2016) Health Aff (Millwood) , vol.35 , pp. 1324-1332
    • Patrick, S.W.1    Fry, C.E.2    Jones, T.F.3    Buntin, M.B.4
  • 82
    • 79955927958 scopus 로고    scopus 로고
    • Prescription drug monitoring programs and death rates from drug overdose
    • Paulozzi LJ, Kilbourne EM, Desai HA (2011). Prescription drug monitoring programs and death rates from drug overdose. Pain Med 12: 747–754.
    • (2011) Pain Med , vol.12 , pp. 747-754
    • Paulozzi, L.J.1    Kilbourne, E.M.2    Desai, H.A.3
  • 83
    • 84903692269 scopus 로고    scopus 로고
    • Vital signs: variation among States in prescribing of opioid pain relievers and benzodiazepines – United States, 2012
    • Paulozzi LJ, Mack KA, Hockenberry JM, Division of Unintentional Injury Prevention NCfIP, Control CDC (2014). Vital signs: variation among States in prescribing of opioid pain relievers and benzodiazepines – United States, 2012. MMWR Morb Mortal Wkly Rep 63: 563–568.
    • (2014) MMWR Morb Mortal Wkly Rep , vol.63 , pp. 563-568
    • Paulozzi, L.J.1    Mack, K.A.2    Hockenberry, J.M.3
  • 84
    • 85018506438 scopus 로고    scopus 로고
    • [Online], (accessed 10/26/16)
    • Peckham C (2016). Medscape Physician Compensation Report 2016. [Online] Available at: http://www.medscape.com/features/slideshow/compensation/2016/public/overview#page=1 (accessed 10/26/16).
    • (2016) Medscape Physician Compensation Report 2016
    • Peckham, C.1
  • 85
    • 84880991284 scopus 로고    scopus 로고
    • Opiate-dependent patients on a waiting list for methadone maintenance treatment are at high risk for mortality until treatment entry
    • Peles E, Schreiber S, Adelson M (2013). Opiate-dependent patients on a waiting list for methadone maintenance treatment are at high risk for mortality until treatment entry. J Addict Med 7: 177–182.
    • (2013) J Addict Med , vol.7 , pp. 177-182
    • Peles, E.1    Schreiber, S.2    Adelson, M.3
  • 86
    • 84891802432 scopus 로고    scopus 로고
    • Hippocampal long-term potentiation is disrupted during expression and extinction but is restored after reinstatement of morphine place preference
    • Portugal GS, Al-Hasani R, Fakira AK, Gonzalez-Romero JL, Melyan Z, McCall JG et al. (2014). Hippocampal long-term potentiation is disrupted during expression and extinction but is restored after reinstatement of morphine place preference. J Neurosci 34: 527–538.
    • (2014) J Neurosci , vol.34 , pp. 527-538
    • Portugal, G.S.1    Al-Hasani, R.2    Fakira, A.K.3    Gonzalez-Romero, J.L.4    Melyan, Z.5    McCall, J.G.6
  • 87
    • 85048951452 scopus 로고    scopus 로고
    • [Online], (accessed 1/10/
    • Post Market Drug Safety Information for Patients and Providers. [Online] Available at: http://www.fda.gov/downloads/drugs/drugsafety/postmarketdrugsafetyinformationforpatientsandproviders/ucm191533.pdf (accessed 1/10/ 2017e).
    • (2017) Post Market Drug Safety Information for Patients and Providers
  • 90
    • 84937643406 scopus 로고    scopus 로고
    • [Online], (accessed 1/16/17)
    • Prescription Drug Monitoring Program Center of Excellence at Brandeis (2014). Briefing on PDMP Effectiveness. [Online] Available at: http://www.pdmpassist.org/pdf/COE_documents/Add_to_TTAC/Briefing%20on%20PDMP%20Effectiveness%203rd%20revision.pdf (accessed 1/16/17).
    • (2014) Briefing on PDMP Effectiveness
  • 91
    • 29844446057 scopus 로고    scopus 로고
    • Synergistic affective analgesic interaction between delta-9-tetrahydrocannabinol and morphine
    • Roberts JD, Gennings C, Shih M (2006). Synergistic affective analgesic interaction between delta-9-tetrahydrocannabinol and morphine. Eur J Pharmacol 530: 54–58.
    • (2006) Eur J Pharmacol , vol.530 , pp. 54-58
    • Roberts, J.D.1    Gennings, C.2    Shih, M.3
  • 93
    • 0038655485 scopus 로고    scopus 로고
    • Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities
    • Rosenblum A, Joseph H, Fong C, Kipnis S, Cleland C, Portenoy RK (2003). Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA 289: 2370–2378.
    • (2003) JAMA , vol.289 , pp. 2370-2378
    • Rosenblum, A.1    Joseph, H.2    Fong, C.3    Kipnis, S.4    Cleland, C.5    Portenoy, R.K.6
  • 94
    • 70349792617 scopus 로고    scopus 로고
    • The neurobiology of addictive disorders
    • Ross S, Peselow E (2009). The neurobiology of addictive disorders. Clin Neuropharmacol 32: 269–276.
    • (2009) Clin Neuropharmacol , vol.32 , pp. 269-276
    • Ross, S.1    Peselow, E.2
  • 95
    • 85008235154 scopus 로고    scopus 로고
    • Increases in drug and opioid-involved overdose deaths – United States, 2010–2015
    • Rudd RA, Seth P, David F, Scholl L (2016). Increases in drug and opioid-involved overdose deaths – United States, 2010–2015. MMWR Morb Mortal Wkly Rep 65: 1445–1452.
    • (2016) MMWR Morb Mortal Wkly Rep , vol.65 , pp. 1445-1452
    • Rudd, R.A.1    Seth, P.2    David, F.3    Scholl, L.4
  • 96
    • 84931576945 scopus 로고    scopus 로고
    • The effect of FAAH, MAGL, and Dual FAAH/MAGL inhibition on inflammatory and colorectal distension-induced visceral pain models in Rodents
    • Sakin YS, Dogrul A, Ilkaya F, Seyrek M, Ulas UH, Gulsen M et al. (2015). The effect of FAAH, MAGL, and Dual FAAH/MAGL inhibition on inflammatory and colorectal distension-induced visceral pain models in Rodents. Neurogastroenterol Motil 27: 936–944.
    • (2015) Neurogastroenterol Motil , vol.27 , pp. 936-944
    • Sakin, Y.S.1    Dogrul, A.2    Ilkaya, F.3    Seyrek, M.4    Ulas, U.H.5    Gulsen, M.6
  • 98
    • 84881367408 scopus 로고    scopus 로고
    • Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal
    • Scavone JL, Sterling RC, Van Bockstaele EJ (2013). Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal. Neuroscience 248: 637–654.
    • (2013) Neuroscience , vol.248 , pp. 637-654
    • Scavone, J.L.1    Sterling, R.C.2    Van Bockstaele, E.J.3
  • 99
    • 84988938832 scopus 로고    scopus 로고
    • Endogenous opioidergic dysregulation of pain in fibromyalgia: a PET and fMRI study
    • Schrepf A, Harper DE, Harte SE, Wang H, Ichesco E, Hampson JP et al. (2016). Endogenous opioidergic dysregulation of pain in fibromyalgia: a PET and fMRI study. Pain 157: 2217–2225.
    • (2016) Pain , vol.157 , pp. 2217-2225
    • Schrepf, A.1    Harper, D.E.2    Harte, S.E.3    Wang, H.4    Ichesco, E.5    Hampson, J.P.6
  • 100
    • 34548483418 scopus 로고    scopus 로고
    • Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors
    • Smith PA, Selley DE, Sim-Selley LJ, Welch SP (2007). Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors. Eur J Pharmacol 571: 129–137.
    • (2007) Eur J Pharmacol , vol.571 , pp. 129-137
    • Smith, P.A.1    Selley, D.E.2    Sim-Selley, L.J.3    Welch, S.P.4
  • 101
    • 84976865494 scopus 로고    scopus 로고
    • The IUPHAR/BPS guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands
    • Southan C, Sharman JL, Benson HE, Faccenda E, Pawson AJ, Alexander SP et al. (2016). The IUPHAR/BPS guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. Nucl Acids Res 44: D1054–D1068.
    • (2016) Nucl Acids Res , vol.44 , pp. D1054-D1068
    • Southan, C.1    Sharman, J.L.2    Benson, H.E.3    Faccenda, E.4    Pawson, A.J.5    Alexander, S.P.6
  • 102
    • 77955912822 scopus 로고    scopus 로고
    • Internet-based interventions for young people with problematic substance use: a systematic review
    • Tait RJ, Christensen H (2010). Internet-based interventions for young people with problematic substance use: a systematic review. Med J Aust 192: S15–S21.
    • (2010) Med J Aust , vol.192 , pp. S15-S21
    • Tait, R.J.1    Christensen, H.2
  • 105
    • 66249125042 scopus 로고    scopus 로고
    • Phasic firing in dopaminergic neurons is sufficient for behavioral conditioning
    • Tsai HC, Zhang F, Adamantidis A, Stuber GD, Bonci A, de Lecea L et al. (2009). Phasic firing in dopaminergic neurons is sufficient for behavioral conditioning. Science 324: 1080–1084.
    • (2009) Science , vol.324 , pp. 1080-1084
    • Tsai, H.C.1    Zhang, F.2    Adamantidis, A.3    Stuber, G.D.4    Bonci, A.5    de Lecea, L.6
  • 106
    • 52349113159 scopus 로고    scopus 로고
    • Common chronic pain conditions in developed and developing countries: gender and age differences and comorbidity with depression-anxiety disorders
    • Tsang A, Von Korff M, Lee S, Alonso J, Karam E, Angermeyer MC et al. (2008). Common chronic pain conditions in developed and developing countries: gender and age differences and comorbidity with depression-anxiety disorders. J Pain 9: 883–891.
    • (2008) J Pain , vol.9 , pp. 883-891
    • Tsang, A.1    Von Korff, M.2    Lee, S.3    Alonso, J.4    Karam, E.5    Angermeyer, M.C.6
  • 107
    • 49649108910 scopus 로고    scopus 로고
    • Predicting opioid misuse by chronic pain patients: a systematic review and literature synthesis
    • Turk DC, Swanson KS, Gatchel RJ (2008). Predicting opioid misuse by chronic pain patients: a systematic review and literature synthesis. Clin J Pain 24: 497–508.
    • (2008) Clin J Pain , vol.24 , pp. 497-508
    • Turk, D.C.1    Swanson, K.S.2    Gatchel, R.J.3
  • 108
    • 85010212721 scopus 로고    scopus 로고
    • [Online], (accessed 1/16/17)
    • US Drug Enforcement Agency (2016). National Heroin Threat Assessment Summary. [Online] Available at: https://www.dea.gov/divisions/hq/2016/hq062716_attach.pdf (accessed 1/16/17).
    • (2016) National Heroin Threat Assessment Summary
  • 110
    • 0028953712 scopus 로고
    • Prevalence and correlates of drug use and dependence in the United States. Results from the National Comorbidity Survey
    • Warner LA, Kessler RC, Hughes M, Anthony JC, Nelson CB (1995). Prevalence and correlates of drug use and dependence in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 52: 219–229.
    • (1995) Arch Gen Psychiatry , vol.52 , pp. 219-229
    • Warner, L.A.1    Kessler, R.C.2    Hughes, M.3    Anthony, J.C.4    Nelson, C.B.5
  • 111
    • 67649216578 scopus 로고    scopus 로고
    • Does report of craving opioid medication predict aberrant drug behavior among chronic pain patients?
    • Wasan AD, Butler SF, Budman SH, Fernandez K, Weiss RD, Greenfield SF et al. (2009). Does report of craving opioid medication predict aberrant drug behavior among chronic pain patients? Clin J Pain 25: 193–198.
    • (2009) Clin J Pain , vol.25 , pp. 193-198
    • Wasan, A.D.1    Butler, S.F.2    Budman, S.H.3    Fernandez, K.4    Weiss, R.D.5    Greenfield, S.F.6
  • 112
    • 84994571368 scopus 로고    scopus 로고
    • Interventions to prevent and reduce physician burnout: a systematic review and meta-analysis
    • West CP, Dyrbye LN, Erwin PJ, Shanafelt TD (2016). Interventions to prevent and reduce physician burnout: a systematic review and meta-analysis. Lancet 388: 2272–2281.
    • (2016) Lancet , vol.388 , pp. 2272-2281
    • West, C.P.1    Dyrbye, L.N.2    Erwin, P.J.3    Shanafelt, T.D.4
  • 113
    • 85006783267 scopus 로고    scopus 로고
    • The endocannabinoid hydrolysis inhibitor SA-57: intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice
    • Wilkerson JL, Ghosh S, Mustafa M, Abdullah RA, Niphakis MJ, Cabrera R et al. (2017). The endocannabinoid hydrolysis inhibitor SA-57: intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice. Neuropharmacology 114: 156–167.
    • (2017) Neuropharmacology , vol.114 , pp. 156-167
    • Wilkerson, J.L.1    Ghosh, S.2    Mustafa, M.3    Abdullah, R.A.4    Niphakis, M.J.5    Cabrera, R.6
  • 115
    • 41949084994 scopus 로고    scopus 로고
    • Ethanol dually modulates GABAergic synaptic transmission onto dopaminergic neurons in ventral tegmental area: role of mu-opioid receptors
    • Xiao C, Ye JH (2008). Ethanol dually modulates GABAergic synaptic transmission onto dopaminergic neurons in ventral tegmental area: role of mu-opioid receptors. Neuroscience 153: 240–248.
    • (2008) Neuroscience , vol.153 , pp. 240-248
    • Xiao, C.1    Ye, J.H.2
  • 116
    • 84947760027 scopus 로고    scopus 로고
    • Mindfulness meditation-based pain relief employs different neural mechanisms than placebo and sham mindfulness meditation-induced analgesia
    • Zeidan F, Emerson NM, Farris SR, Ray JN, Jung Y, McHaffie JG et al. (2015). Mindfulness meditation-based pain relief employs different neural mechanisms than placebo and sham mindfulness meditation-induced analgesia. J Neurosci 35: 15307–15325.
    • (2015) J Neurosci , vol.35 , pp. 15307-15325
    • Zeidan, F.1    Emerson, N.M.2    Farris, S.R.3    Ray, J.N.4    Jung, Y.5    McHaffie, J.G.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.